11/11
09:11 am
xgn
Exagen Inc. to Participate in Fourth Quarter Investor Conferences [Yahoo! Finance]
Medium
Report
Exagen Inc. to Participate in Fourth Quarter Investor Conferences [Yahoo! Finance]
11/11
09:00 am
xgn
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Medium
Report
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
11/10
08:03 am
xgn
Exagen (NASDAQ:XGN) had its price target raised by analysts at BTIG Research from $13.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
Exagen (NASDAQ:XGN) had its price target raised by analysts at BTIG Research from $13.00 to $15.00. They now have a "buy" rating on the stock.
11/7
02:43 am
xgn
How Analyst Views Are Shifting the Story for Exagen Amid New Growth Signals [Yahoo! Finance]
Medium
Report
How Analyst Views Are Shifting the Story for Exagen Amid New Growth Signals [Yahoo! Finance]
11/5
10:03 am
xgn
Exagen (NASDAQ:XGN) had its "buy" rating reaffirmed by analysts at B. Riley.
Low
Report
Exagen (NASDAQ:XGN) had its "buy" rating reaffirmed by analysts at B. Riley.
11/4
07:50 pm
xgn
Exagen (XGN): Revenue Growth Outlook Challenges Bearish Sentiment as Valuation Remains Undemanding [Yahoo! Finance]
Medium
Report
Exagen (XGN): Revenue Growth Outlook Challenges Bearish Sentiment as Valuation Remains Undemanding [Yahoo! Finance]
11/4
08:00 am
xgn
Exagen Inc. Reports Strong Q3 2025 Results
Medium
Report
Exagen Inc. Reports Strong Q3 2025 Results
10/27
08:06 am
xgn
Exagen (NASDAQ:XGN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $11.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
Exagen (NASDAQ:XGN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $11.00 to $15.00. They now have a "buy" rating on the stock.
10/23
09:15 am
xgn
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
Low
Report
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
10/22
08:34 am
xgn
Exagen (NASDAQ:XGN) had its price target raised by analysts at BTIG Research from $11.00 to $13.00. They now have a "buy" rating on the stock.
Low
Report
Exagen (NASDAQ:XGN) had its price target raised by analysts at BTIG Research from $11.00 to $13.00. They now have a "buy" rating on the stock.
10/21
05:05 pm
xgn
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025 [Yahoo! Finance]
Low
Report
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025 [Yahoo! Finance]
10/21
04:05 pm
xgn
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
Low
Report
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
10/14
07:19 am
xgn
Exagen (NASDAQ:XGN) was given a new $15.00 price target on by analysts at KeyCorp. They now have an "overweight" rating on the stock.
Medium
Report
Exagen (NASDAQ:XGN) was given a new $15.00 price target on by analysts at KeyCorp. They now have an "overweight" rating on the stock.
10/2
07:22 am
xgn
With 38% stake, Exagen Inc. (NASDAQ:XGN) seems to have captured institutional investors' interest [Yahoo! Finance]
Low
Report
With 38% stake, Exagen Inc. (NASDAQ:XGN) seems to have captured institutional investors' interest [Yahoo! Finance]
9/13
08:39 am
xgn
Exagen's Momentum Meets Execution Risks: Why I Choose To HOLD For Now [Seeking Alpha]
Medium
Report
Exagen's Momentum Meets Execution Risks: Why I Choose To HOLD For Now [Seeking Alpha]
9/12
06:17 am
xgn
Exagen (NASDAQ:XGN) was upgraded by analysts at B. Riley to a "strong-buy" rating.
Medium
Report
Exagen (NASDAQ:XGN) was upgraded by analysts at B. Riley to a "strong-buy" rating.
9/11
08:08 am
xgn
Exagen (NASDAQ:XGN) is now covered by analysts at B. Riley. They set a "buy" rating and a $15.00 price target on the stock.
Low
Report
Exagen (NASDAQ:XGN) is now covered by analysts at B. Riley. They set a "buy" rating and a $15.00 price target on the stock.